Biogen (BIIB) Price to Book (2009 - 2026)

Biogen has reported Price to Book for 18 years, with the latest figure at 1.69 in Q2 2026.

• On a quarterly basis, Price to Book rose 62.21% year-over-year to 1.69 in Q2 2026; TTM through Jun 2026 was 1.69, a 62.21% increase from a year earlier, with the FY2025 full-year figure at 1.42, up 6.1% from the prior year.
• Price to Book was 1.69 for Q2 2026 at Biogen, up from 1.45 in the prior quarter.
• The five-year high for Price to Book was 3.01 in Q3 2022, with the low at 1.04 in Q2 2025.
• Average Price to Book over 5 years is 2.07, with a median of 2.09 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Price to Book plunged 50.87% in 2025, then surged 62.21% in 2026.
• Over 5 years, Price to Book stood at 2.98 in 2022, then retreated by 14.94% to 2.53 in 2023, then sank by 47.36% to 1.33 in 2024, then advanced by 6.1% to 1.42 in 2025, then rose by 19.69% to 1.69 in 2026.
• The last three Price to Book figures came in at 1.69 (Q2 2026), 1.45 (Q1 2026), and 1.42 (Q4 2025), per Business Quant data.